Financials in USD. Standardized financial statements.
A compact view of how MEDIROM Healthcare Technologies Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.04M | $8.30B | $6.83B | $6.95B | $5.41B | $3.34B | $3.91B | $3.43B |
| Revenue Growth? | -100.0% | +21.5% | -1.8% | +28.5% | +61.9% | -14.5% | +13.8% | 0.0% |
| Cost of Revenue? | $137,794 | $6.05B | $5.26B | $5.05B | $3.99B | $2.91B | $2.96B | $2.48B |
| Gross Profit? | $3.90M | $2.25B | $1.57B | $1.90B | $1.42B | $428.95M | $950.76M | $956.87M |
| Gross Margin? | +96.6% | +27.1% | +23.0% | +27.4% | +26.2% | +12.8% | +24.3% | +27.9% |
| Operating Expenses? | $3.49M | $2.26B | $1.96B | $1.81B | $1.89B | $1.18B | $916.41M | $883.60M |
| Operating Income? | $414,306 | -$18.10M | -$391.58M | $96.97M | -$470.59M | -$746.09M | $34.35M | $73.27M |
| EBITDA? | $513,791 | $387.50M | $310.08M | $373.63M | -$276.29M | -$551.16M | $125.07M | $158.31M |
| Income Before Tax | $379,900 | $47.71M | $20.62M | $179.77M | -$414.48M | -$626.69M | $33.30M | $91.56M |
| Income Tax Expense | $5,180 | -$90.48M | -$94.43M | $30.81M | $576.25M | -$87.52M | $15.96M | $25.25M |
| Net Income? | $374,720 | $148.76M | $115.05M | $148.97M | -$990.73M | -$539.17M | $17.34M | $66.31M |
| EPS? | $7.43 | $29.13 | $23.64 | $30.54 | $-203.13 | $-133.97 | $4.28 | $16.60 |
| Diluted EPS? | $7.43 | $26.74 | $22.27 | $27.23 | $-203.13 | $-133.97 | $4.06 | $14.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality